Tricia SterlingVice President Patient Affairs at Aeglea
Tricia Sterling has over 20 years of experience in the pharmaceutical and biotechnology space with the majority of her time working with patients and caregivers with rare diseases. Prior to joining Aeglea, Tricia was the head of Patient Services at Amicus Therapeutics where she was responsible for developing the company’s patient support program in preparation for the first US product launch. Prior to Amicus Therapeutics, Tricia spent several years at Retrophin, now Travere, where she led both the Patient Services and Patient Advocacy Departments working with patients and caregivers with rare and ultra rare diseases. Earlier in her career she held roles at Shire HGT (now Takeda) and Biogen. Tricia received both her B.A. in Business Administration and Communications and her M.B.A. in Management from the University of St. Thomas in St. Paul, MN.